STUDY ON CLINICAL, PARACLINICAL AND EFFICACY OF GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES AND COMPLICATIONS OF CHRONIC KIDNEY DISEASE AT KIEN GIANG GENERAL HOSPITAL IN 2021-2022

Van Mo Le1,, Van Phuc Ha2, Hoang Khai Truong3
1 Medical center of Vinh Thuan District, Kien Giang Province
2 Kien Giang Department of Health
3 Kien Giang General Hospital

Main Article Content

Abstract

Background: Kidney complications are a very serious problem for patients with diabetes. When patients with diabetes have complications, good blood sugar control is very important. Objectives: To evaluate the results of glycemic control in patients with type 2 diabetes mellitus with complications of chronic kidney disease at Kien Giang General Hospital in 2021-2022. Materials and methods: A descriptive cross-sectional study on 96 patients with type 2 diabetes with complications of chronic kidney disease. Results: The mean duration of disease of 96 patients was 11 ± 8.7 years, 27.1% of subjects belonged to high blood pressure group; All patients were in stage 3 or more renal failure. 85.0% of patients were treated with insulin alone. According to KDOQI's HbA1c index, in 2020 the success rate of sugar control was 24.0%. In the 3 stages of renal failure, the rate of glycemic control in the group with stage 5 renal failure accounted for the highest rate of 46.2%, the difference between these groups was not statistically significant (p > 0.05). Similarly, the study did not find a statistically significant relationship between the effectiveness of blood sugar control and blood pressure history (p > 0.05). Conclusion: Results of successful blood sugar control in patients with type 2 diabetes with complications of chronic kidney disease at Kien Giang General Hospital, from November 2021 to June 2022, was not high (less than 40%).

Article Details

References

1. Kê Thị Lan Anh (2021), Nghiên cứu đặc điểm lâm sàng, cận lâm sàng và đánh giá biến chứng thận ở bệnh nhân đái tháo đường type 2 tại khoa Nội 3, Bệnh viện Hữu Nghị Việt Tiệp-Hải Phòng, Công trình nghiên cứu khoa học trường Đại học Y Dược Hải Phòng, Tạp chí Y học Việt Nam, tập 503, tháng 6, Số đặc biệt, tr.386-394.
2. Bộ Y Tế, (2020), Hướng dẫn chẩn đoán và điều trị đái tháo đường typ 2, Quyết định số 5481/QĐ-BYT, ngày 30/12/2020.
3. Đỗ Gia Tuyển (2021), Bệnh thận do đái tháo đường, Bệnh học nội khoa tập 2, Nhà xuất bản Y học 2021, Tr 21-41.
4. ADA (2021), Glycemic Targets: Standards of Medical Care in Diabetes, Diabetes 2021, Diabetes Care; 44 (Supplement_1):S73–S84.
5. Improving Global Outcomes (KDIGO) Diabetes Work Group (2020), KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease, Official journal of the internatinal society of nephrology. 98(4S): S1-S115.
6. National Kidney Foundation (2012), KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 update. Am J Kidney Dis. 2012;60(5):850-886.
7. Sankar D. Navaneethan, Sophia Zoungas, M. Luiza Caramori, et al (2020), Diabetes Management in Chronic Kidney Disease: Synopsis of the 2020 KDIGO, Ann Intern Med, 174(3):385-394.